Shatavari Powder

  • Product may be contaminated with elevated levels of lead.
  • Company: New York Wholesale Group
  • Food & Beverages
  • FDA
  • January 27, 2025

Product details

  • Shatavari Powder

Company announcement

New York Wholesale Group is recalling Zaarah Herbals Shatavari Powder due to potential contamination with elevated levels of lead.

The product was distributed to retailers in New York, New Jersey, Connecticut, and California between October 21, 2022, and April 15, 2024.

No illnesses have been reported as of January 27, 2025.

Risk:

Short term exposures to very low levels of lead may not elicit any symptoms. It is possible that increased blood lead levels may be the only apparent sign of lead exposure. Additional overt signs and symptoms of lead exposure are more likely with acute exposure to higher levels of lead. While lead can affect nearly every bodily system, its effects depend upon the amount and duration of lead exposure and age/ body weight. If a fetus is exposed to enough lead for a protracted period of time (e.g., weeks to months) permanent damage to the central nervous system may occur. This can result in learning disorders, developmental defects, and other long-term health problems. For adults, chronic lead exposure is associated with kidney dysfunction, hypertension, increased risk of mortality from cardiovascular disease, and neurocognitive effects.

Impacted states: NY, NJ, CT, CA

Products:

- Zaarah Herbals Shatavari Powder (UPC code(s): 63502899940)

Contact

For more information, call 1-800-516-7606.

View the original FDA notice

Browse all recalls

Related recalls